Infliximab is an appropriate second-line therapy in infants with steroid refractory pyoderma gangrenosum

Affiliations

¹ Department of Pediatrics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
² Department of Pediatrics, Children's Hospital Sankt Augustin, Sankt Augustin, Germany.
³ Department of Pediatrics, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
⁴ Department of Dermatology, Hospital Infantil Universitario Niño Jesús, Universidad Autónoma de Madrid, Madrid, Spain.
⁵ Department of Dermatology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

L M Lesmeister et al. J Eur Acad Dermatol Venereol. 2022 May.

. 2022 May;36(5):e376-e378.

doi: 10.1111/jdv.17921. Epub 2022 Jan 27.

¹ Department of Pediatrics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
² Department of Pediatrics, Children's Hospital Sankt Augustin, Sankt Augustin, Germany.
³ Department of Pediatrics, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
⁴ Department of Dermatology, Hospital Infantil Universitario Niño Jesús, Universidad Autónoma de Madrid, Madrid, Spain.
⁵ Department of Dermatology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

No abstract available

References

1. Crouse L, McShane D, Morrell DS, Wu EY. Pyoderma gangrenosum in an infant: a case report and review of the literature. Pediatr Dermatol 2018; 35(5): e257-e261.
1. Alavi A, French LE, Davis MD, Brassard A, Kirsner RS. Pyoderma gangrenosum: an update on pathophysiology, diagnosis and treatment. Am J Clin Dermatol 2017; 18(3): 355-372.
1. Marzano AV, Borghi A, Meroni PL, Cugno M. Pyoderma gangrenosum and its syndromic forms: evidence for a link with autoinflammation. Br J Dermatol 2016; 175(5): 882-891.
1. Etzler C, Cannon S, Hyde P. Refractory pyoderma gangrenosum in an infant. Pediatr Dermatol 2015; 32(1): 156-157.
1. Rajan N, Das S, Taylor A, Abinun M, Spencer D, Carmichael A. Idiopathic infantile pyoderma gangrenosum with stridor responsive to infliximab. Pediatr Dermatol 2009; 26(1): 65-69.